Impact on postoperative bleeding and cost of recombinant activated factor VII in patients undergoing heart transplantation

Impact on postoperative bleeding and cost of recombinant activated factor VII in patients undergoing heart transplantation

Background: Cardiac transplantation can be complicated by refractory hemorrhage particularly in cases where explantation of a ventricular assist device is necessary. Recombinant activated factor VII (rFVIIa) has been used to treat refractory bleeding in cardiac surgery patients, but little informati...

Full description

Bibliographic Details
Main Authors: Allison L Hollis, Ashleigh V Lowery, Mehrnaz Pajoumand, Si M Pham, Julia F Slejko, Kenichi A Tanaka, Michael Mazzeffi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:Annals of Cardiac Anaesthesia
Subjects:
Bleeding; Heart transplantation; Recombinant activated factor VII; Transfusion
Online Access:http://www.annals.in/article.asp?issn=0971-9784;year=2016;volume=19;issue=3;spage=418;epage=424;aulast=Hollis

Internet

http://www.annals.in/article.asp?issn=0971-9784;year=2016;volume=19;issue=3;spage=418;epage=424;aulast=Hollis

Similar Items